Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Bell Grimes

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of Pediatrics|March 30, 2019
50 Years Ago in The Journal of Pediatrics: Thiamine-Responsive Megaloblastic AnemiaDolores Mullikin, Amanda Bell Grimes
Pediatric Blood & Cancer|December 31, 2019
The cost of a "benign" condition: Healthcare utilization and infectious outcomes in young children with primary autoimmune neutropeniaSusan E Kirk, Amanda Bell Grimes, Sayali Shelke, et al.
Blood Advances|January 9, 2025
Working toward international consensus defining pediatric "refractory ITP"Candelaria O'Farrell, Amanda Bell Grimes, Taizo A Nakano, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of Pediatrics|March 30, 2019
50 Years Ago in The Journal of Pediatrics: Thiamine-Responsive Megaloblastic AnemiaDolores Mullikin, Amanda Bell Grimes
Pediatric Blood & Cancer|December 31, 2019
The cost of a "benign" condition: Healthcare utilization and infectious outcomes in young children with primary autoimmune neutropeniaSusan E Kirk, Amanda Bell Grimes, Sayali Shelke, et al.
Blood Advances|January 9, 2025
Working toward international consensus defining pediatric "refractory ITP"Candelaria O'Farrell, Amanda Bell Grimes, Taizo A Nakano, et al.
Pageof 1